StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > LOI Carr

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon May 27, 2021 11:38am

70 Views

Post# 33275699

RE:RE:RE:RE:RE:RE:RE:LOI Carr

In life and business it really all comes down to who you know.

I was against the CAre thing to begine with but the company is made up of cancer pros that have years of experience and they made something of their buisness

Its nice to think about all the contacts they have made while building their business, going through schooling, etc

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale